Participants were randomly assigned to hemoglobin A@c goals of < @ % ( < @ mmol/mol ; intensive glycemia ) or @-@ @ % ( @-@ mmol/mol ; standard glycemia ) and then randomized a second time to either @ ) systolic BP goals of < @ mmHg ( intensive BP ) or < @ mmHg ( standard BP ) or @ ) simvastatin plus fenofibrate ( intensive lipid ) or simvastatin plus placebo ( standard lipid ) .